BioXcel Therapeutics, Inc.

BTAI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$37,320$17,435$31,013$29,854
Short-Term Investments$0$0$0$0
Receivables$0$17$0$131
Inventory$459$506$642$679
Other Curr. Assets$6,624$7,285$6,122$6,730
Total Curr. Assets$44,403$25,243$37,777$37,394
Property Plant & Equip (Net)$389$546$702$857
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$87$87
Total NC Assets$389$546$789$944
Other Assets$0$0$0$0
Total Assets$44,792$25,789$38,566$38,338
Liabilities
Payables$16,276$16,692$15,450$15,990
Short-Term Debt$16,984$11,472$5,958$374
Tax Payable$0$108$65$91
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,544$5,104$4,073$5,778
Total Curr. Liab.$37,804$33,376$25,546$22,233
LT Debt$92,302$97,469$99,918$102,573
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,605$2,611$3,274$6,633
Total NC Liab.$95,907$100,080$103,192$109,206
Other Liabilities$0$0$0$0
Cap. Leases$0$256$350$439
Total Liabilities$133,711$133,456$128,738$131,439
Equity
Pref Stock$0$0$0$0
Common Stock$73$60$59$49
Retained Earnings-$707,549-$676,638-$657,451-$650,197
AOCI$0$0$0$0
Other Equity$618,557$568,911$567,220$557,047
Total Equity-$88,919-$107,667-$90,172-$93,101
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$44,792$25,789$38,566$38,338
Net Debt$71,966$91,506$74,863$73,093
BioXcel Therapeutics, Inc. (BTAI) Financial Statements & Key Stats | AlphaPilot